我如何管理患有血液性恶性瘤的患者的急性呼吸衰竭
Elie Azoulay1, Johan Maertens2,3, Virginie Lemiale1
1Intensive Care Department, Saint-Louis University Hospital, Paris-Cité University, Paris, France.
Blood
|January 17, 2024
概括
血液性恶性瘤患者的急性呼吸衰竭 (ARF) 需要及时诊断以获得更好的结果. 直接方法有助于识别ARF的原因,减少死亡率和不必要的治疗.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 肺部病理学 肺部病理学
背景情况:
- 急性呼吸衰竭 (ARF) 是血液恶性瘤患者 (包括白血病和接受干细胞移植的患者) 的常见和致命并发症.
- 在这个脆弱人群中,ARF是重症监护室 (ICU) 入院的主要驱动因素,病例死亡率为35%.
研究的目的:
- 强调急需在患有ARF的血液性恶性瘤患者中进行快速和准确的诊断工作的关键需求.
- 引入并倡导在指导ARF的诊断调查中采用DIRECT方法在这个患者群体中.
主要方法:
- 直接方法用于估计预测诊断概率,考虑诸如诊断延迟,免疫缺陷模式,放射学发现,临床经验和整体临床情况等因素.
- 优先进行快速诊断测试,以潜在地避免侵入性手术,如带有支气管支气管洗的支气管镜检查,这可能会破坏低血症患者的稳定.
主要成果:
- 及时的病因诊断与死亡率降低有关.
- 及时诊断将经验性治疗的持续时间降到最低,从而降低阳性损害和医疗保健成本.
结论:
- 在血液性恶性瘤患者中,ARF的有效管理取决于一个结构良好的诊断策略,例如DIRECT方法.
- 密切跨学科的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切的密切
- 通过适当的氧气输送来最大限度地减少侵入性机械通风,并专注于ICU环境中的恶性瘤治疗,是恢复的关键桥梁.
相关概念视频
Acute Respiratory Failure-V
141
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
141
Acute Respiratory Failure-I
212
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
212
Acute Respiratory Failure-II
238
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
238
Acute Respiratory Failure-IV
158
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
158
Acute Respiratory Failure-III
187
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187
Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331


